Cargando…

Cognitive dysfunction in severe chronic obstructive pulmonary disease (COPD) with or without Long-Term Oxygen Therapy (LTOT)

BACKGROUND: Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory condition which can lead to comorbidities of variable severity, cognitive dysfunction included. The role of supplemental oxygen in preventing COPD-induced cognitive deterioration is still debated, but only episodic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dal Negro, Roberto W, Bonadiman, Luca, Bricolo, Fernanda P, Tognella, Silvia, Turco, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415443/ https://www.ncbi.nlm.nih.gov/pubmed/25932326 http://dx.doi.org/10.1186/s40248-015-0013-4

Ejemplares similares

Extent and prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values
por: Dal Negro, Roberto W, et al.
Publicado: (2014)

Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update
por: Dal Negro, Roberto W, et al.
Publicado: (2015)

Changes in blood hemoglobin and blood gases PaO(2) and PaCO(2) in severe COPD overa three-year telemonitored program of long-term oxygen treatment
por: Dal Negro, Roberto W, et al.
Publicado: (2012)

Sensitivity of the COPD assessment test (CAT questionnaire) investigated in a population of 681 consecutive patients referring to a lung clinic: the first Italian specific study
por: Negro, Roberto W Dal, et al.
Publicado: (2014)

Prevalence of different comorbidities in COPD patients by gender and GOLD stage
por: Dal Negro, R. W., et al.
Publicado: (2015)

Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
por: Dal Negro, Roberto W., et al.
Publicado: (2018)

Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
por: Dal Negro, Roberto W., et al.
Publicado: (2018)

Fluticasone furoate/vilanterol 92/22 µg once a day: a 12-month study on outcomes in mild to moderate asthma
por: Dal Negro, Roberto W., et al.
Publicado: (2018)

Prophylactic function of excellent compliance with LTOT in the development of pulmonary hypertension due to COPD with hypoxemia
por: Xiong, Wei, et al.
Publicado: (2018)

Oxidant status, iron homeostasis, and carotenoid levels of COPD patients with advanced disease and LTOT
por: Kentson, M., et al.
Publicado: (2018)

The Global Usability Score Short-Form for the simplified assessment of dry powder inhalers (DPIs) usability
por: Povero, Massimiliano, et al.
Publicado: (2020)

Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/ Formoterol 100/6 μg b.i.d.: a 12-week cost analysis in mild-to-moderate asthma
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

Cost of persistent asthma in Italy
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

Instant velocity and consistency of emitted cloud change by the different levels of canister filling with Metered Dose Inhalers (MDIs), but not with Soft Mist Inhalers (SMIs): a bench study
por: Dal Negro, Roberto W., et al.
Publicado: (2017)

Patients’ usability of seven most used dry-powder inhalers in COPD
por: Dal Negro, Roberto W., et al.
Publicado: (2019)

Correction to: Patients’ usability of seven most used dry-powder inhalers in COPD
por: Dal Negro, Roberto W., et al.
Publicado: (2019)

LTOT Patients’ Experience of a Portable Oxygen Unit and Health-Related Quality of Life—A Cross-Sectional Study
por: Möller, Sebastian, et al.
Publicado: (2020)

Prevalence of tracheobronchomalacia and excessive dynamic airway collapse in bronchial asthma of different severity
por: Dal Negro, Roberto W, et al.
Publicado: (2013)

Cost-effectiveness of the COPD Patient Management European Trial home-based disease management program
por: Bourbeau, Jean, et al.
Publicado: (2019)

Optimizing economic outcomes in the management of COPD
por: Dal Negro, Roberto
Publicado: (2008)

Effects of Adherence to Once-Daily Treatment on Lung Function, Bronchial Hyperreactivity and Health Outcomes in Adolescents with Mild-to-Moderate Asthmoka: A Twelve-Month Survey
por: Dal Negro, Roberto W., et al.
Publicado: (2022)

The Extra Cost Due to Non-Adherence to Inhaled Treatments in Adolescents with Mild-to-Moderate Persistent Asthma
por: Dal Negro, Roberto Walter, et al.
Publicado: (2023)

Cost of acute cough in Italian children
por: Negro, Roberto W Dal, et al.
Publicado: (2018)

The Emotional Response to Pandemic of Middle- and High-School Students of an Italian Northern Province: The ERP Study
por: Povero, Massimiliano, et al.
Publicado: (2022)

The contribution of patients’ lung function to the inspiratory airflow rate achievable through a DPIs’ simulator reproducing different intrinsic resistance rates
por: Dal Negro, Roberto W., et al.
Publicado: (2021)

Comparison of Consistency, Feasibility, and Convenience of a Novel Compact System for Assessing Lung Volumes and Carbon Monoxide Diffusing Capacity versus Whole Body Plethysmography
por: Dal Negro, Roberto W, et al.
Publicado: (2021)

Lung Function Can Predict the Expected Inspiratory Airflow Rate through Dry Powder Inhalers in Asthmatic Adolescents
por: Dal Negro, Roberto Walter, et al.
Publicado: (2022)

Nebivolol: an effective option against long-lasting dyspnoea following COVID-19 pneumonia - a pivotal double-blind, cross-over controlled study
por: Dal Negro, Roberto W., et al.
Publicado: (2022)

Long-lasting dyspnoea in patients otherwise clinically and radiologically recovered from COVID pneumonia: a probe for checking persisting disorders in capillary lung volume as a cause
por: Dal Negro, Roberto W., et al.
Publicado: (2022)

Prevalence and clinical features of most frequent phenotypes in the Italian COPD population: the CLIMA Study
por: Dal Negro, Roberto W., et al.
Publicado: (2021)

Cough: impact, beliefs, and expectations from a national survey
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

Influenza and influenza-like syndromes: the subjects’ beliefs, the attitude to prevention and treatment, and the impact in Italian general population
por: Dal Negro, Roberto W., et al.
Publicado: (2018)

Acute cough in Italian children: parents’ beliefs, approach to treatment, and the family impact
por: Dal Negro, Roberto W., et al.
Publicado: (2019)

COPD: The Annual Cost-Of-Illness during the Last Two Decades in Italy, and Its Mortality Predictivity Power
por: Dal Negro, Roberto W.
Publicado: (2019)

Acceptability and preference of three inhalation devices assessed by the Handling Questionnaire in asthma and COPD patients
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

The BODECOST Index (BCI): a composite index for assessing the impact of COPD in real life
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

An international randomized study of a home-based self-management program for severe COPD: the COMET
por: Bourbeau, Jean, et al.
Publicado: (2016)

Left ventricular dysfunction in COPD without pulmonary hypertension
por: Hilde, Janne M., et al.
Publicado: (2020)

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
por: Calverley, Peter MA, et al.
Publicado: (2019)

Airflow obstruction: is it asthma or is it COPD?
por: Rogliani, Paola, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lsd8jjmejipotg45kn2ino9440